XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues    
Total revenues, net $ 29,042,837 $ 18,198,112
Cost of revenues    
Total cost of revenues 5,248,175 3,211,057
Gross profit 23,794,662 14,987,055
Expenses    
Selling and marketing expenses 21,909,825 18,640,731
General and administrative expenses 12,302,478 7,021,541
Other operating expenses 1,327,734 636,787
Customer service expenses 933,307 295,277
Development costs 428,333 311,056
Total expenses 36,901,677 26,905,392
Operating loss (13,107,015) (11,918,337)
Interest expense, net (167,934) (139,463)
Gain on debt forgiveness 184,914
Net loss (13,274,949) (11,872,886)
Net income (loss) attributable to non-controlling interest 24,726 (270,503)
Net loss attributable to LifeMD, Inc. (13,299,675) (11,602,383)
Preferred stock dividends (776,563)
Net loss attributable to LifeMD, Inc. common stockholders $ (14,076,238) $ (11,602,383)
Basic loss per share attributable to LifeMD, Inc. common stockholders $ (0.46) $ (0.47)
Diluted loss per share attributable to LifeMD, Inc. common stockholders $ (0.46) $ (0.47)
Weighted average number of common shares outstanding:    
Basic 30,853,118 24,467,788
Diluted 30,853,118 24,467,788
Telehealth Revenue Net [Member]    
Revenues    
Total revenues, net $ 22,598,061 $ 13,283,315
Work Simpli Revenue Net [Member]    
Revenues    
Total revenues, net 6,444,776 4,914,797
Cost Of Telehealth Revenue [Member]    
Cost of revenues    
Total cost of revenues 5,086,068 3,123,025
Cost Of Work Simpli Revenue [Member]    
Cost of revenues    
Total cost of revenues $ 162,107 $ 88,032